Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Spinal morphine doses compared for C-Section pain relief

NCT ID NCT07516717

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two doses of spinal morphine (75 vs 100 micrograms) in 240 women having planned C-sections to see which provides better pain control with fewer side effects. Pain was measured using a standard scale over 24 hours after surgery. The goal is to find the best dose to improve recovery and comfort for new mothers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
morphine
What this could lead to
If successful, this could help doctors choose the safest, most effective dose of spinal morphine for pain relief after C-sections, improving recovery for mothers.
What could go wrong
This is a small, completed Phase 4 trial with 240 participants, so results may not apply to all patients. The difference between doses may be small, and side effects like nausea or itching are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

240 people

The number who actually took part.

Started

Jan 2023

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women scheduled for elective cesarean delivery under spinal anesthesia. * Age between 18 and 45 years. * ASA physical status II * Singleton term pregnancy. * Ability to provide written informed consent. Exclusion Criteria: * Contraindications to spinal anesthesia. * Known allergy or hypersensitivity to morphine or opioids. * Chronic opioid use or opioid dependence. * Significant systemic disease (ASA more or equal to III). * Pregnancy complications (e.g., preeclampsia, eclampsia). * Body mass index more than 40 kg/m2. * Infection at the puncture site. * Coagulopathy or anticoagulant therapy. * Refusal to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario de Caracas

    Caracas, Miranda, 1040, Venezuela

More trials for these conditions

Other studies related to the condition(s) this trial covers.